This company has been marked as potentially delisted and may not be actively trading. NightHawk Biosciences (NHWK) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock NHWK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period SCPXD Scorpius Holdings, Inc.July 20, 2024 | seekingalpha.comScorpius Holdings GAAP EPS of -$1.74April 29, 2024 | seekingalpha.comScorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major UniversityMarch 19, 2024 | globenewswire.comScorpius Holdings Accepted as a Member of the US Government's BioMaP-ConsortiumMarch 14, 2024 | globenewswire.comScorpius Holdings, Inc. Announces Closing of Public OfferingMarch 12, 2024 | globenewswire.comScorpius Holdings, Inc. Announces Pricing of Public OfferingMarch 7, 2024 | globenewswire.comScorpius Holdings, Inc. Announces Proposed Public Offering of Common StockMarch 7, 2024 | globenewswire.comScorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023March 7, 2024 | globenewswire.comScorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023March 7, 2024 | globenewswire.comScorpius Holdings, Inc. (SCPX)February 13, 2024 | uk.finance.yahoo.comNightHawk Biosciences Debuts SCPX Ticker on NYSE AmericanFebruary 7, 2024 | msn.comNightHawk Biosciences Unveils New Name and TickerFebruary 7, 2024 | msn.comNightHawk Biosciences Strikes Key Licensing and Financing DealsJanuary 31, 2024 | msn.comNightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing NoteJanuary 30, 2024 | finance.yahoo.comNightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical ProgramJanuary 25, 2024 | finance.yahoo.comNightHawk Biosciences: NightHawk's Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New ClientJanuary 16, 2024 | finanznachrichten.deNightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New ClientJanuary 16, 2024 | finance.yahoo.comNHWK: Transformational ChangesJanuary 11, 2024 | msn.comNightHawk Biosciences changing name to Scorpius, ticker to SCPXJanuary 8, 2024 | msn.comNightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMOJanuary 8, 2024 | finance.yahoo.comNightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National UniversityJanuary 3, 2024 | finance.yahoo.comNightHawk Biosciences Announces Completion of Demonstration Run for a Top-Tier NIH and DTRA Funded Research UniversityDecember 21, 2023 | finance.yahoo.comNightHawk Biosciences files for $200M mixed securities shelfDecember 19, 2023 | msn.comNightHawk Biosciences Announces Major Milestone with Completion of Manufacturing Run for a Premier U.S.-Based Biopharmaceutical CompanyDecember 18, 2023 | finance.yahoo.comNightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core AssetsDecember 12, 2023 | finance.yahoo.comNightHawk Biosciences Inc NHWKDecember 3, 2023 | morningstar.comMMorrisville public company looks to divest subsidiary after CEO tried to buy itNovember 29, 2023 | bizjournals.comNightHawk Biosciences reports Q3 resultsNovember 20, 2023 | msn.comNightHawk Biosciences Provides Q3 2023 Business UpdateNovember 20, 2023 | finance.yahoo.comNHWK: 2Q:23 ResultsOctober 9, 2023 | finance.yahoo.comMorrisville CEO pitches to buy his company's subsidiary for $45M+August 24, 2023 | finance.yahoo.comMorrisville CEO wants to acquire his company's subsidiary for $45M+August 24, 2023 | finance.yahoo.comNightHawk Biosciences CEO Offers to Buy Its Elusys UnitAugust 21, 2023 | marketwatch.comNightHawk Biosciences GAAP EPS of -$0.53 misses by $0.08, revenue of $0.7M misses by $0.2MAugust 15, 2023 | seekingalpha.comNightHawk Biosciences Provides Q2 2023 Business UpdateAugust 14, 2023 | finance.yahoo.comNHWK: First Scorpius RevenuesMay 19, 2023 | finance.yahoo.comNightHawk Biosciences GAAP EPS of -$0.49May 15, 2023 | msn.comNightHawk Biosciences Provides Q1 2023 Business UpdateMay 15, 2023 | finance.yahoo.comBrookline Capital Downgrades NightHawk Biosciences (NHWK)May 2, 2023 | msn.comNightHawk Biosciences Stock (AMEX:NHWK), DividendsApril 28, 2023 | benzinga.comNHWK: ANTHIM Sales Boost RevenuesApril 11, 2023 | finance.yahoo.comMaxim Group Downgrades Nighthawk Biosciences (NHWK)April 4, 2023 | msn.comNightHawk Biosciences's Return On Capital Employed InsightsApril 3, 2023 | msn.comNightHawk Biosciences Provides 2022 Year End Business UpdateMarch 31, 2023 | finance.yahoo.comNightHawk Biosciences, Inc. (NHWK)March 23, 2023 | ca.finance.yahoo.comNHWK: Shifting Focus to BiomanufacturingDecember 12, 2022 | finance.yahoo.comNightHawk Biosciences Provides Third Quarter 2022 Business UpdateNovember 15, 2022 | finance.yahoo.comNew VelocityTX biomanufacturer increases jobs target as new production facility nears completionOctober 25, 2022 | bizjournals.comNighthawk Biosciences' Scorpion Subsidiary Announces Grand Opening of its San Antonio FacilityOctober 21, 2022 | technews.tmcnet.comNighthawk Biosciences’ Scorpion Subsidiary Announces Grand Opening of its San Antonio FacilityOctober 21, 2022 | finance.yahoo.com Get NightHawk Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NHWK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NHWK Media Mentions By Week NHWK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NHWK News Sentiment▼0.001.05▲Average Medical News Sentiment NHWK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NHWK Articles This Week▼00▲NHWK Articles Average Week Get the Latest News and Ratings for NHWK and Related Stocks Enter your email address to receive the latest news and analysts' ratings for NightHawk Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Eagle Pharmaceuticals News Aadi Bioscience News PyroGenesis Canada News NanoViricides News iBio News Matinas Biopharma News AEON Biopharma News NovaBay Pharmaceuticals News NeuroBo Pharmaceuticals News China Pharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NHWK) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NightHawk Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NightHawk Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
